Speakers



Keynote:


      George Q. Daley, M.D., Ph.D., Samuel E. Lux IV Professor of Hematology/Oncology and Director of the Stem Cell Transplantation Program at Boston Children’s Hospital

Dr. Daley seeks to translate insights in stem cell biology into improved therapies for genetic and malignant diseases. Important research contributions from his laboratory include the creation of customized stem cells to treat genetic immune deficiency in a mouse model (together with Rudolf Jaenisch), the differentiation of germ cells from embryonic stem cells (cited as a “Top Ten Breakthrough” by Science magazine in 2003), and the generation of disease-specific pluripotent stem cells by direct reprogramming of human fibroblasts (cited in the “Breakthrough of the Year” issue of Science magazine in 2008).  As a graduate student working with Nobelist Dr. David Baltimore, Dr. Daley demonstrated that the BCR/ABL oncogene induces chronic myeloid leukemia (CML) in a mouse model, which validated BCR/ABL as a target for drug blockade and encouraged the development of imatinib (GleevecTM; Novartis), a revolutionary magic-bullet chemotherapy that induces remissions in virtually every CML patient. Dr. Daley’s recent studies have clarified mechanisms of Gleevec resistance and informed novel combination chemotherapeutic regimens.

Dr. Daley received his bachelor's degree magna cum laude from Harvard University (1982), a Ph.D. in biology from MIT (1989), and the M.D. from Harvard Medical School, where he was only the twelfth individual in the school’s history to be awarded the degree summa cum laude (1991). He served as Chief Resident in Internal Medicine at the Massachusetts General Hospital (94-95) and is currently a staff physician in Hematology/Oncology at the Children's Hospital and the Dana Farber Cancer Institute, and a member of the Hematology Division of the Brigham and Women’s Hospital in Boston. He has been elected to the Institute of Medicine of the National Academies, the American Society for Clinical Investigation, the American Association of Physicians, and the American Pediatric Societies, and is a fellow of the American Academy of Arts and Sciences and the American Association for the Advancement of Science. Dr. Daley was an inaugural winner of the NIH Director’s Pioneer Award for highly innovative research and has received the Judson Daland Prize from the American Philosophical Society for achievement in patient-oriented research, the E. Mead Johnson Award from the American Pediatric Society for contributions to stem cell research, and the E. Donnall Thomas Prize of the American Society for Hematology for advances in human induced pluripotent stem cells.

Dr. Daley is the Samuel E. Lux IV Professor of Hematology/Oncology and Director of the Stem Cell Transplantation Program at Boston Children’s Hospital. He is also Professor of Biological Chemistry and Molecular Pharmacology, Medicine, and Pediatrics at Harvard Medical School, an investigator of the Howard Hughes Medical Institute, Associate Director of Children’s Stem Cell Program, founding member of the Executive Committee of the Harvard Stem Cell Institute, and past-President of the International Society for Stem Cell Research (2007-2008).


      Michael J. Zinner, M.D., FACS, Moseley Professor of Surgery at Harvard Medical School, the Surgeon-in-Chief at the Brigham and Women’s Hospital (BWH) and the Clinical Director of the Dana Farber/Brigham and Women’s Cancer Center

Dr. Zinner is a member of the editorial boards of several surgical journals, including Annals of Surgery, Journal of Gastrointestinal Surgery and the Journal of the American College of Surgeons. He is the past and current Editor for “Maingot’s Abdominal Operations”, a worldwide textbook and atlas of gastrointestinal surgery.

Dr. Zinner was past President of the Association for Academic Surgery, past President of the Society of the University Surgeons and past President of the Society of Surgical Chairman.  He has previously served as a Director of the American Board of Surgery, a member of the Board of Directors of the Society of Surgery of the Alimentary Tract and a member of the Board of Directors of Collegium Internationale Chirurgiac Digestivae.  In 2008, he received the National Award for the Advancement of Women in Surgery from the Association of Women Surgeons (AWS).  He was the Chairman of the Board of Governors of the American College of Surgeons (ACS) from 2008 to 2010 and is now a Regent of the College.

In 2004, he established the Center for Surgery and Public Health (CSPH), a collaboration between the Harvard Medical School and the Harvard School of Public Health, focused on healthcare, quality, safety and effectiveness and global surgical care. The CSPH has mentored many national prominent surgeons into important positions all over the globe. His current interests include these areas and the national debate on health care reform. He is active in local, regional and national organizations on health care policies and is Vice Chairman of the American College of Surgeons Health Care Policy and Advocacy Committee - representing 75,000 Fellows of the ACS.  For the past 4 years he has taught courses on health care at the Heller School for Social Policy and Management at Brandeis University and was recently appointed Adjunct Professor there. He has been on the Boards of several hospitals and health care systems across the country and is a member of The Robert Wood Johnson Foundation National Advisory Committee beginning 2013.

Dr. Zinner remains a busy clinician and his clinical focus centers on diseases of the gastrointestinal tract.  He enjoys his practice and interactions with residents and students, and has received teaching awards for both.

Board of Advisors:


      Steve A. N. Goldstein, M.A., M.D., Ph.D., F.A.A.P., Chairman of the Global Youth Summit on the Future of Medicine

Dr. Goldstein became provost of Brandeis University on September 1, 2011 and serves as the chief academic officer and the second ranking member of the administration, responsible for all areas of the university. Dr. Goldstein is a leading authority on mechanisms underlying normal function of the heart and brain and sudden, life-threatening diseases. He did his pediatric internship, residency and a clinical fellowship in pediatric medicine and cardiology at Children’s Hospital Boston.

From 1993 to 2004, Goldstein was on the faculty at the Yale University School of Medicine and founded the Section of Developmental Biology and Biophysics. In 2004, he moved to the University of Chicago to become Chair of the Department of Pediatrics and Physician-in-Chief at Comer Children’s Hospital. While at Chicago he founded the Institute for Molecular Pediatric Sciences and co-founded the Institute for Translational Medicine. He is a fellow of the American Academy of Pediatrics and in 2001 received the E. Mead Johnson Award for pediatric research. From 2002 to 2007, he was editor-in-chief of the Quarterly Review of Biophysics.

Dr. Goldstein grew up in New York City and came to Brandeis in 1974 as an undergraduate. He earned B.A. and M.A. degrees in biochemistry in 1978, graduating Phi Beta Kappa. Goldstein holds an M.D. and Ph.D. in immunology from Harvard University and is an accomplished scientist and scholar.


Plenary:


      Andrew Flagel, Ph.D., Senior Vice President for Students and Enrollment and Senior Lecturer at Brandeis University

Dr. Flagel’s research and writing focuses on student success in college, admissions policies and practices, and organizational communication in higher education. His article, "Revisiting the High School Visit," was selected for the Journal of College Admission 75th Anniversary Edition. As Senior Vice President for Students and Enrollment, Dr. Flagel supervises the offices of admissions, community living (housing), athletics, financial aid, student accounts, the Hiatt Career Center, the Health Center, the Interfaith Chaplaincy, the Intercultural Center, and student activities.

Prior to joining Brandeis, Dr. Flagel was associate vice president for enrollment development and dean of admissions at George Mason University, where he also taught in the department of communication, was executive director for the Washington Journalism and Media Conference and the Washington Youth Summit on the Environment, and served as advisor to the university band and the Jewish Student Association. Before Mason, he was the director of admissions at the Flint campus of the University of Michigan. He also served as the director of enrollment management for the Congressional Youth Leadership Council, and as a regional director of admissions at George Washington University (GW).

Dr. Flagel holds a Ph.D. in education with a concentration in communication from the College of Education at Michigan State University, as well as a B.A. in psychology and philosophy and an M.A. in education and human development, each from GW.


      Robert Sackstein, M.D., Ph.D., Brigham and Women's Hospital and the Dana-Farber Cancer Institute Professor, Co-Director of the Graduate Education in Medical Sciences (GEMS) Program, Harvard Medical School and Massachusetts Institute of Technology, Director of the Program of Excellence in Glycosciences, Harvard Medical School

Dr. Sackstein is a bone marrow transplant physician and basic scientist who performs glycoscience-based bench research inspired by medical necessity. He received his undergraduate degree from Harvard College, summa cum laude in Biology, and his M.D. and Ph.D. degrees in Immunology from Harvard Medical School, where he also received the James Tolbert Shipley Prize for outstanding research. He then completed internal medicine training and fellowships in immunology and hematology at the University of Miami, and received the Young Investigator Award for Excellence in the Field of Hematology from the International Society for Experimental Hematology.

Dr. Sackstein's efforts as a scientist and clinician are intimately intermeshed. He is an immunologist/cell biologist/biochemist with clinical expertise in internal medicine/hematology/immunology and, in particular, in hematopoietic stem cell transplantation (HSCT). His bench research efforts aim to elucidate biologic processes critical to improving outcomes for patients undergoing stem cell transplantation. In particular, Dr. Sackstein’s research efforts have defined many of the molecular effectors of adult stem cell and leukocyte migration. He is widely recognized for developing a platform glycoengineering technology (known as "GPS") for programming cellular migration to sites of tissue injury.


Panelists:


      Anne E. Becker, M.D., Ph.D., Maude and Lillian Presley Professor of Global Health and Social Medicine and Associate Professor of Psychiatry at Harvard Medical School

Dr. Becker is the Maude and Lillian Presley Professor of Global Health and Social Medicine and Associate Professor of Psychiatry at Harvard Medical School. She is also Vice Chair of the Department of Global Health and Social Medicine as well as Director of the Social Sciences M.D.-Ph.D. Program at Harvard Medical School. An anthropologist and psychiatrist, Dr. Becker has combined ethnographic, other qualitative, and epidemiologic methods in her research to focus on the impact of social and cultural environment on mental health. She was also the lead investigator of research on the impact of television on the body image of teenage girls in Fiji.

Dr. Becker is the author of Body, Self, and Society: The View from Fiji, which probes the cultural mediation of self-agency and body experience. More recently, Dr. Becker's NIMH-funded research has investigated the impact of rapid economic and social transition on eating pathology, suicide, and other youth health risk behaviors in Fiji. Presently, also with NIMH support, she and co-PI Pere Eddy Eustache of Zanmi Lasante are conducting a mental health research capacity building project and novel school-based youth mental health pilot intervention in central Haiti.


      Susan Dalelio, Senior Vice President of Accounts, Program and Expansion, Health Leads National

Ms. Dalelio is Senior Vice President of Accounts, Program and Expansion, Health Leads National, a non-profit organization that seeks to connect patients in underserved communities with access to resources and care. With more than 20 years of senior-level experience in for-profit and nonprofit management, Ms. Dalelio brings to Health Leads a strong record of direct experience building and developing teams, fundraising, managing programs, cultivating and stewarding comprehensive partnerships and creating organization-wide tools and systems.

Ms. Dalelio began her career with audience development work for Shear Madness/Cranberry Productions, one of the nation’s longest-running theatrical productions. She then moved into the nonprofit sector with her role as the Director of Registration and Student Services at the Boston Center for Adult Education (BCAE), and eventually as its first Director of Development. After the BCAE, she became Director of Posse Boston at The Posse Foundation, an acclaimed national college access and diversity program.

Ms. Dalelio then rose to Regional Vice President at Posse and worked to help implement the strategic plan and ensure overall health of the organization while overseeing the Boston, Miami, New Orleans, and New York City chapters. In that role, she supported and developed Posse’s programming, fundraising, and institutional partnerships. A native of the Boston area, for college Ms. Dalelio ventured out to the University of Michigan, Ann Arbor, where she earned a B.A. in art history and economics.


      Nancy L. Keating, MD, MPH, Associate Professor of Medicine and of Health care Policy at Harvard Medical School and an Associate Physician at Brigham and Women’s Hospital.

Dr. Keating’s research focuses on the quality of care delivered to patients with cancer and the influence of physicians, hospitals, and health care systems on care delivery. Other work has assessed communication between patients and physicians and among physicians.

Dr. Keating is an active participant in the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium, funded by the National Cancer Institute (NCI)—a collaborative effort to examine patterns of care and outcomes for patients with colorectal and lung cancer. Dr. Keating is also studying the quality of care delivered to patients diagnosed with cancer in the Veterans Administration health care system. Additionally, she has been funded by the NCI to investigate long-term outcomes after breast cancer treatments in community populations of patients, and she is examining adverse effects of hormonal therapy used in the treatment of men with prostate cancer. In work funded by the Komen for the Cure Foundation, she is examining the contribution of health care providers in explaining racial disparities in breast cancer care. In related work, she is exploring breast cancer diagnosis and treatment in Latin America.  In addition, Dr. Keating has recently been funded by the American Cancer Society to assess the influence of Massachusetts health insurance reform on breast cancer screening and diagnosis.

Dr. Keating was a recipient of a Doris Duke Clinical Scientist Award, an award of the Doris Duke Charitable Foundation that supports young investigators beginning their careers as independent clinical researchers. In 2005, she was selected as the Society of General Internal Medicine’s junior investigator of the year. She currently serves as a member of the editorial board of the Journal of Clinical Oncology and she is a member of the National Comprehensive Cancer Center Senior Oncology Guideline Panel.

Dr. Keating graduated summa cum laude from Virginia Tech. She received her M.D. degree from the University of Chicago, Pritzker School of Medicine, and her M.P.H. degree from the Harvard School of Public Health.

      Swapnil Maniar, Ph.D., Director of Health Equity Programs in the Brigham and Women’s Hospital Center for Community Health and Health Equity and Instructor in Medicine in the BWH Division of General Medicine and Harvard Medical School

Dr. Maniar is currently the Director of Health Equity Programs in the Brigham and Women’s Hospital Center for Community Health and Health Equity and is an Instructor in Medicine in the BWH Division of General Medicine and Harvard Medical School. Dr. Maniar collaborates with clinical and community partners to develop and implement innovative programs to eliminate health disparities related to infant mortality, cardiovascular disease, cancer, violence, asthma, and other chronic diseases among residents of some of Boston’s most underserved neighborhoods.

Prior to joining Brigham and Women’s, Dr. Maniar was the founding Director of the Massachusetts Youth Violence Prevention Program at the Massachusetts Department of Public Health. His work focused on integrating a comprehensive youth development approach to community-based youth violence prevention. The program supports innovative youth violence prevention approaches grounded in youth development theory. Dr. Maniar also founded and co-chaired the Massachusetts Coalition for Youth Violence Prevention. This coalition consisted of over 40 community-based organizations, academic centers, state agencies, and faith-based organizations.

Dr. Maniar received his Ph.D. from the Johns Hopkins University Bloomberg School of Public Health in 2005. His doctoral research examined correlates of weapon carrying behavior among adolescents in the United States. Dr. Maniar received his Master’s in Public Health (MPH) from the Yale University School of Public Health in 1998 and his Bachelor’s degree in 1994 from Connecticut College with a double major in English and Zoology.


      Beth Nicklas, Esq., Vice President and Counsel for Academic and Research Programs, Mass Life Sciences Center

Ms. Nicklas brings a diverse background of private and public sector experience to her position at the Massachusetts Life Sciences Center. She has experience in legal analysis, regulatory and policy development, program management, and performance metrics. She spent 13 years working for quasipublic and state agencies, most recently in economic development, and served as a consultant to the federal government for 6 years with the Cambridge-based firm of Industrial Economics.

Ms. Nicklas developed, implemented, and manages the Center’s $12.6 million dollar Research Matching Grant Program, which provides funding to academic institutions working in the life sciences. Funding includes grants for new investigators that are seeking to establish independent laboratories, faculty positions to attract star scientists to positions in Massachusetts, and industry-sponsored grants that encourage partnerships between university investigators engaged in translational research and life sciences companies seeking to commercialize new products. Ms. Nicklas was responsible for working closely with members of the Center’s Scientific Advisory Board and developing a peer review process modeled on the approach used by the National Institutes of Health, generally considered the “gold standard.”

Ms. Nicklas’s other signature program is the Internship Challenge Program, designed to provide internship opportunities in the life sciences sector to undergraduates studying science, technology, engineering, and math (STEM) subjects. In the program’s inaugural year last summer, the Center placed 104 interns from 29 colleges or universities in 59 research institutions and life sciences companies throughout the Commonwealth. This year, the Center’s Board approved a 50% increase in funding for a second year of the program, with 10% of the internships targeted at community college students.

Ms. Nicklas is a graduate of Columbia University School of Law and holds a Masters in Public Administration from the Kennedy School of Government at Harvard. She was a recipient of the prestigious Bradford Fellowship awarded to outstanding managers working in state government.


Featured:


      Lisa Russell, Emmi Award-winning Documentary Filmmaker

Ms. Russell is an Emmy Award-winning documentary filmmaker who uses the power of film to explore and challenge social injustices that affect our collective humanity. Completing her Master's in Public Health degree in International Health in 1998, Ms. Russell has since turned a lens to pressing global health and development topics that has taken her to shoots in some of the world's most remote locations. Some of her work has been broadcasted on public television (including PBS and Channel 4 London), while others are tied into advocacy, fundraising or legislative efforts with UN and international agencies. She actively screens her films around the country at universities, conferences, festivals and hill briefings and has reached thousands of students, young people and others to spark dialogue about U.S. responsibility in global affairs.

In September 2005, Ms. Russell collaborated with Grammy-nominated artist Zap Mama to create "The WOMAN Tour" - a 3-week nationwide initiative of film screenings and musical performances to increase awareness of global women's health. Ms. Russell was chosen as one of 25 filmmakers for the National Black Programming Consortium's New Media Institute, is a two-time producer for WGBH's Lab Open Call and is a 2008 recipient of a New York State Council on the Arts (NYSCA) grant and a Paul Robeson Fund for Independent Media Grant.

In May 2009, Ms. Russell won a Boston/New England Emmy Award in the "Outstanding Advanced Media Interactivity" category for her short film, "Bi-Racial Hair." Currently residing in Brooklyn, NY, she is a teaching artist with Urban Word NYC, the city's leading non-profit providing workshops in spoken word poetry and creative writing for NYC teens.